Citadel Advisors’s First Trust Indxx Medical Devices ETF MDEV Stock Holding History
Bought
Maintained
Sold
Other funds holding MDEV
GT
AAP
HI
Citadel Advisors's MDEV Position: Q2 2024 in Review
Citadel Advisors sold out of First Trust Indxx Medical Devices ETF (MDEV) in Q2 2024, closing a stake of 11,130 shares — an estimated $238K sold.
Citadel Advisors first reported a position in MDEV in Q4 2021 and held it in 7 quarters. The position peaked at $432K in Q1 2022. 7 funds tracked by Wall St. Rank hold MDEV as of Q2 2024.
- Citadel Advisors reported no remaining First Trust Indxx Medical Devices ETF position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 11,130 First Trust Indxx Medical Devices ETF shares in Q2 2024, an estimated $238K.
- Citadel Advisors first reported a position in First Trust Indxx Medical Devices ETF in Q4 2021 and held it in 7 quarters.
- Citadel Advisors's First Trust Indxx Medical Devices ETF position peaked at $432K in Q1 2022.
- 7 funds tracked by Wall St. Rank held First Trust Indxx Medical Devices ETF as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.